Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Kensey Nash and St. Jude Medical settle royalties spat. More news briefs.

You may also be interested in...



DSM Buys Device Component Maker Kensey Nash To Bolster Biomedical Materials Offerings

Deal worth $360 million will help establish DSM as a major device industry materials supplier, strengthening offerings of bio-passive, bio-active and bio-interactive materials technologies.

Congress Passes Lab Cuts; Obama Budget Targets Include Imaging, DME

Labs and test makers were caught off guard by a significant reimbursement cut passed in a payroll tax cut/physician payment fix bill. The same week, President Obama submitted a 2013 budget request that targets imaging and durable medical equipment with cuts and restrictions.

News In Brief

Industry guides on ethical distribution pacts. Stryker settles charges over OP-1 marketing. Terumo buys Onset Medical. More news briefs.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031080

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel